The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in ...

Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...

RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

Dementia therapies may help relieve symptoms, but many different options are available. Some may help more than others.

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...